Agilent to Sponsor Global Forensics Congress in Portugal
News Aug 27, 2013
Agilent Technologies Inc. has announced that it will host a series of scientific presentations at the annual meeting of the International Association of Forensic Toxicologists (TIAFT), Sept. 2-6, in Madeira, Portugal.
TIAFT is a prominent international forensics trade association. Its annual congress draws hundreds of forensic and analytical toxicologists from all over the world.
“For over a decade, Agilent has been a proud sponsor of TIAFT’s international meetings and the association’s mission to promote education, training and research in forensic toxicology and related disciplines,” said Tom Gluodenis, Agilent’s global marketing manager of Forensics and Toxicology. “We are pleased to continue our support for this forum highlighting the latest advances in measurement technology.”
Agilent Program Highlights
Tuesday evening keynote address: “Analytical Identification - At the Core of the EU Early Warning System,” presented by Dr. Andrew Cunningham of the European Monitoring Centre for Drugs & Drug Addiction, Lisbon.
Wednesday technical presentation: “Latest Advances in GC/MS, LC/MS, Spectroscopy and Sample-Preparation Technologies for Isometric/Designer Drugs, Drug Metabolite Analysis and Trace Metal Analysis,” presented by Agilent scientists Bernhard Wüest, Juan Aybar, Jaume Morales, Dr. Amparo Villar and Laure Blanc.
Poster presentation: “Ethylglucuronide Determination in Hair as an Indicator of Chronic Alcohol Abuse - A Fully Validated Method in GC-EI-MS/MS,” presented by Dr. Jennifer Pascali, DTOLabs (Agilent authorized partner laboratory), Resana, Italy, and Dr. Franco Tagliaro, Department of Public Health and Community Medicine, Section of Forensic Medicine, University of Verona, Verona, Italy.
Attendees are also invited to visit Agilent’s exhibit (Booth No. 1) to talk with scientists and view the company’s latest advances in sample-preparation technology, chromatography, spectrometry and mobile-measurement solutions for use in forensic toxicology, anti-doping initiatives and related applications.
Test For Designer Drugs Could Help Treat Overdose PatientsNews
Medical professionals are scrambling to meet the growing demand for emergency room treatment, but they’re hampered by the lack of a quick and easy test to screen patients for “designer” drugs. Chemists have now developed such a test and are refining it with the hope that hospitals could eventually use it to choose the appropriate treatment.READ MORE
Exposure to Low Levels of BPA during Pregnancy Can Lead to Altered Brain DevelopmentNews
New research in mice provides an explanation for how exposure to the widely used chemical bisphenol A (BPA) during pregnancy, even at levels lower than the regulated “safe” human exposure level, can lead to altered brain development and behavior later in life.READ MORE
Moving Toward a Future Free of Drug-Induced Hearing LossNews
A new special publication orchestrated by five of the nation's leading hearing experts compiles the latest research into hearing loss caused by drugs and solvents - how it occurs, how to treat it, and how to prevent it.READ MORE
Comments | 0 ADD COMMENT
World Congress on Advanced Pharmacy and Clinical Research
Jul 16 - Jul 17, 2018
11th International Conference and Exhibition on Metabolomics & Systems Biology
May 17 - May 19, 2018
World Congress on Pathology and Laboratory Medicine
Sep 10 - Sep 11, 2018